retatrutide dosing frequency clinical trial VisualAbstract: reduces body weight by 17.5% in patients with obesity retatrutide clinical trial dosing frequency

GLP-1 for weight loss Medically reviewed by Dr Crystal Wyllie Last reviewed: 19 Jun 2026 Glucagon-like peptide-1 (GLP-1) agonists are a popular weight loss treatment in the UK

Compared to MedVi, T-Mates plays in a similar cash-pay lane but emphasizes a cleaner pricing structure without the titration-based upcharges some MedVi patients have flagged

In addition, regular injections have also been shown to have cardiovascular benefits

All in all, its a no-fuss, prescription-first approach without any upsells

D., Klammt, S., Posch, M

Sold under names like Wegovy or Ozempic, Semaglutide mimics a hormone called GLP-1 that helps regulate hunger and blood sugar